← Back to directory

Wojciech Wojakowski

Researcher Next ID · RN-041308

Researcher · Medicine

Cedars-Sinai Medical Center

Los Angeles, Poland

Accepting doctoral researchersFunding unknown
Works count
685
Citation count
13,773
H-index
47
i10-index
193

Research interests

Medicine
Coronary Interventions and Diagnostics
Cardiac Valve Diseases and Treatments
Cardiac Imaging and Diagnostics
Acute Myocardial Infarction Research
Peripheral Artery Disease Management

Publications

  • Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation

    New England Journal of Medicine · 2025 · 10.1056/nejmoa2406674

  • 2025 ESC/EACTS Guidelines for the management of valvular heart disease

    European Heart Journal · 2025 · https://doi.org/10.1093/eurheartj/ehaf194

  • Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

    European Heart Journal · 2024 · 10.1093/eurheartj/ehae579

  • Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

    New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2314328

  • 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

    European Heart Journal · 2022 · 10.1093/eurheartj/ehac270

  • Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial

    Circulation · 2021 · 10.1161/circulationaha.121.057639

  • Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab433

  • Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension

    JACC: Cardiovascular Interventions · 2020 · 10.1016/j.jcin.2019.10.048

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31792-x

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31792-x

  • Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries

    Circulation · 2017 · 10.1161/circulationaha.116.023381

  • Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

    European Heart Journal · 2016 · 10.1093/eurheartj/ehw543

  • Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients With Acute Myocardial Infarction Based on Individual Patient Data

    Circulation Research · 2015 · 10.1161/circresaha.116.304346

  • Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis

    European Heart Journal · 2013 · 10.1093/eurheartj/eht372

  • Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?

    Leukemia · 2011 · 10.1038/leu.2011.389

  • Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction

    European Heart Journal · 2010 · 10.1093/eurheartj/ehq305

  • Innate immunity as orchestrator of stem cell mobilization

    Leukemia · 2010 · 10.1038/leu.2010.162

  • Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

    European Heart Journal · 2009 · https://doi.org/10.1093/eurheartj/ehp073

  • Mobilization of Bone Marrow-Derived Oct-4+ SSEA-4+ Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction

    Journal of the American College of Cardiology · 2008 · 10.1016/j.jacc.2008.09.029

  • Role of Kinin B2Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential

    Circulation Research · 2008 · 10.1161/circresaha.108.179952

  • A hypothesis for an embryonic origin of pluripotent Oct-4+ stem cells in adult bone marrow and other tissues

    Leukemia · 2007 · 10.1038/sj.leu.2404630

  • Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood – preliminary report

    Leukemia · 2006 · 10.1038/sj.leu.2404470

  • The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis

    Leukemia · 2006 · 10.1038/sj.leu.2404357

  • Mobilization of CD34/CXCR4 + , CD34/CD117 + , c-met + Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction

    Circulation · 2004 · https://doi.org/10.1161/01.cir.0000147609.39780.02

  • The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction.

    PubMed · 2004

Current projects

    No projects listed.